European Archives - Page 377 of 1014 - European Medical Journal

The Green Radiology Department

GLOBALLY, hospital-based care has a substantial ecological footprint. In the USA, the health sector generates approximately 10% of the…

Beyond Aesthetics: Hyaluronic Acid Fillers as a Therapeutic Treatment

Any filler injection requires a bespoke treatment approach and a thorough anatomy knowledge to minimise procedural risks and achieve…

The Role of Harm Reduction in Smoking Cessation Strategies

Worldwide, tobacco use causes more than 7 million deaths every year, a death toll that could increase to 8 million by the end of the…

Interview: Grant Blashki

Grant Blashki- Associate Professor, Nossal Institute for Global Health, University of Melbourne, Victoria, Australia; Adjunct Associate Pr…

Interview: Karly Hampshire

Karly Hampshire Medical Student, University of California, San Francisco, USA; Founder and Co-director, Planetary Health Report Card; Fell…

Demystifying the Discussion of Sequencing Panel Size in Oncology Genetic Testing

Clinical laboratories worldwide are implementing next-generation sequencing (NGS) to identify cancer genomic variants and ultimately…

Lymphoepithelial Cysts of the Pancreas: CT and MRI Features

Objective: Describe CT and MRI features of the lymphoepithelial cyst (LEC) of the pancreas.Methods: The authors identified 13 cases…

Emetogenicity of Chemotherapy Regimens and Recommended Prophylaxis: A Review of MASCC/ESMO Guidelines

This article reviews the impact of CINV, the emetogenic risk associated with different chemotherapy regimens in solid tumours and haematologic malignancies, and guideline-based recommendations for antiemetic prophylaxis according to emetogenic risk.

Total Plasma Exchange for Hypertriglyceridaemia Complicated by Acute Pancreatitis: A Case Report

Hypertriglyceridaemia pancreatitis (HGTP) accounts for 1–35% of acute pancreatitis (AP) cases.1 Acute pancreatitis is an acute…

The physics of pharmacovigilance

A highly-effective pharmacovigilance function is a rising value differentiator for pharmaceutical companies. Read to find out more about the challenges.